Marina C. Muñoz

1.6k total citations
38 papers, 1.3k citations indexed

About

Marina C. Muñoz is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marina C. Muñoz has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marina C. Muñoz's work include Renin-Angiotensin System Studies (17 papers), Apelin-related biomedical research (13 papers) and Receptor Mechanisms and Signaling (10 papers). Marina C. Muñoz is often cited by papers focused on Renin-Angiotensin System Studies (17 papers), Apelin-related biomedical research (13 papers) and Receptor Mechanisms and Signaling (10 papers). Marina C. Muñoz collaborates with scholars based in Argentina, United States and Chile. Marina C. Muñoz's co-authors include Fernando P. Dominici, Jorge F. Giani, Daniel Turyn, Jorge E. Toblli, Mariela M. Gironacci, Marcos Mayer, Valeria Burghi, Gabriel Cao, Carlos A. Taira and Johanna G. Miquet and has published in prestigious journals such as PLoS ONE, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Marina C. Muñoz

37 papers receiving 1.3k citations

Peers

Marina C. Muñoz
Henry L. Keen United States
Elaine Hillas United States
Xiaohan Lu United States
Marina C. Muñoz
Citations per year, relative to Marina C. Muñoz Marina C. Muñoz (= 1×) peers Luigi Mattiello

Countries citing papers authored by Marina C. Muñoz

Since Specialization
Citations

This map shows the geographic impact of Marina C. Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina C. Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina C. Muñoz more than expected).

Fields of papers citing papers by Marina C. Muñoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina C. Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina C. Muñoz. The network helps show where Marina C. Muñoz may publish in the future.

Co-authorship network of co-authors of Marina C. Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Marina C. Muñoz. A scholar is included among the top collaborators of Marina C. Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina C. Muñoz. Marina C. Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muñoz, Marina C., et al.. (2023). Acute In Vivo Administration of Compound 21 Stimulates Akt and ERK1/2 Phosphorylation in Mouse Heart and Adipose Tissue. International Journal of Molecular Sciences. 24(23). 16839–16839. 2 indexed citations
2.
Muñoz, Marina C., Verónica Piazza, Valeria Burghi, et al.. (2022). Insulin signaling in the heart is impaired by growth hormone: a direct and early event. Journal of Molecular Endocrinology. 69(2). 357–376.
3.
Burghi, Valeria, et al.. (2019). Participation of Gαi-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways. Frontiers in Pharmacology. 10. 146–146. 13 indexed citations
4.
Miquet, Johanna G., Lorena González, Ana I. Sotelo, et al.. (2019). Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity. Molecular and Cellular Endocrinology. 498. 110587–110587. 11 indexed citations
5.
Burghi, Valeria, Verónica Piazza, Érica Guilhen Mário, et al.. (2017). Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies. PLoS ONE. 12(8). e0183278–e0183278. 20 indexed citations
6.
Muñoz, Marina C., et al.. (2016). Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice. Peptides. 88. 37–45. 18 indexed citations
7.
Mayer, Marcos, Christián Höcht, Marina C. Muñoz, et al.. (2013). Central insulin–angiotensin II interaction in blood pressure regulation in fructose overloaded rats. Regulatory Peptides. 185. 37–43. 5 indexed citations
8.
Toblli, Jorge E., Gabriel Cao, Jorge F. Giani, et al.. (2011). Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats. Journal of Hypertension. 29(8). 1613–1623. 23 indexed citations
9.
Espelt, María V., Diego O. Croci, María L Bacigalupo, et al.. (2011). Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. Hepatology. 53(6). 2097–2106. 50 indexed citations
10.
Muñoz, Marina C., Jorge F. Giani, & Fernando P. Dominici. (2010). Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regulatory Peptides. 161(1-3). 1–7. 54 indexed citations
11.
Muñoz, Marina C., Jorge F. Giani, Marcos Mayer, et al.. (2009). TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. Journal of Endocrinology. 201(2). 185–197. 45 indexed citations
12.
Miquet, Johanna G., Marina C. Muñoz, Jorge F. Giani, et al.. (2009). Ames dwarf (Prop1/Prop1) mice display increased sensitivity of the major GH-signaling pathways in liver and skeletal muscle. Growth Hormone & IGF Research. 20(2). 118–126. 9 indexed citations
13.
Muñoz, Marina C., Jorge F. Giani, Fernando P. Dominici, Daniel Turyn, & Jorge E. Toblli. (2009). Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats. Journal of Hypertension. 27(12). 2409–2420. 44 indexed citations
14.
Bonkowski, Michael S., Marina C. Muñoz, Michał M. Masternak, et al.. (2008). Insulin Signaling Cascade in the Hearts of Long-Lived Growth Hormone Receptor Knockout Mice: Effects of Calorie Restriction. The Journals of Gerontology Series A. 63(8). 788–797. 22 indexed citations
16.
Polizio, Ariel H., et al.. (2006). BEHAVIOUR OF THE ANTI‐OXIDANT DEFENCE SYSTEM AND HEME OXYGENASE‐1 PROTEIN EXPRESSION IN FRUCTOSE‐HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 33(8). 734–739. 15 indexed citations
17.
Muñoz, Marina C., et al.. (2006). Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. Journal of Hypertension. 24(8). 1607–1617. 40 indexed citations
18.
19.
Dominici, Fernando P., et al.. (2005). Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Hormone & IGF Research. 15(5). 324–336. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026